GDL Fund The (GDL) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 12.4x for GDL Fund The). abrdn Life Sciences Investors pays a dividend yielding 11.01%, while GDL Fund The does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | GDL | HQL |
|---|---|---|
| Share price | $8.33 | $17.35 |
| Market cap | $89.49M | — |
| 1-day change | +0.24% | -1.20% |
| YTD return | — | +4.65% |
| 1-year return | — | +11.21% |
| 5-year return | — | -15.00% |
| P/E ratio (TTM) | 12.43 | 2.61 |
| EPS (TTM) | $0.67 | $6.64 |
| Dividend yield | 5.78% | 11.01% |
| Annual dividend | $0.00 | $1.91 |
| 52-week high | $8.67 | $22.67 |
| 52-week low | $8.01 | $15.66 |
| Distance from 52-week high | -3.92% | -23.47% |
| Average volume | 10.87K | 147.31K |
| Shares outstanding | 10.74M | — |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GDL Fund The trades at a higher earnings multiple (12.4x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (11.01% vs 5.78%).
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
GDL vs HQL FAQ
Which has the lower P/E ratio, GDL or HQL?
HQL has the lower trailing P/E at 2.6, versus 12.4 for GDL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, GDL Fund The or abrdn Life Sciences Investors?
abrdn Life Sciences Investors has the higher yield at 11.01%, compared with 5.78% for GDL Fund The.
Are GDL Fund The and abrdn Life Sciences Investors in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.